[Estrogen and progesterone receptors in cancer of the breast]

Digital health technology in oncology: results from a survey by the ESMO Young Oncologists Committee and medical student alumni.

ESMO real world data and digital oncology·2026

Opportunities and challenges in implementing digital patient-centred cancer care in Europe-a qualitative study of several ESMO Designated Centres.

ESMO real world data and digital oncology·2026

Prognostic impact of pathological complete response and response-adapted outcomes in patients with gastroesophageal adenocarcinoma treated with neoadjuvant or perioperative treatments: a multicentric cohort study.

ESMO open·2026

Gastric cancer hospital-based registry: real-world gastric cancer data from Latin America and Europe.

ESMO gastrointestinal oncology·2026

Clinical decision impact of HER2DX, an algorithm-powered genomic diagnostic in early-stage HER2-positive breast cancer: results from a prospective real-world study.

ESMO real world data and digital oncology·2026

Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial.

ESMO open·2025

Q fever in Spain: Epidemiology and demographic characteristics of hospitalized patients (2016-2023).

Medicina clinica·2026

Disease progression in transthyretin cardiac amyloidosis treated with disease-modifying therapies: a multicenter real-world experience.

Medicina clinica·2026

Allergic bronchopulmonary aspergillosis as a poor prognostic factor in cystic fibrosis patients with atelectasis.

Medicina clinica·2026

Overview of breast cancer screening in Spain and its impact on mortality: An ecological study examining temporal trends (2000-2023).

Medicina clinica·2026

One-year outcomes in patients with heart failure and chronic kidney disease: differences according to the type of heart failure and kidney disease stages.

Medicina clinica·2026

Agent-based simulation and digital twins in heart failure care: Current evidence, validation and implementation barriers.

Medicina clinica·2026

Exploratory machine-learning analysis of bevacizumab exposure and circulating VEGF dynamics in patients with cancer.

Frontiers in pharmacology·2026

Ulcerative colitis reporting across medications: FAERS analysis and cross-species transcriptomic triangulation.

Frontiers in immunology·2026

A novel CAF-related gene signature for prognostic and immunotherapy response prediction in PDAC based on single-cell RNA-seq and bulk RNA-seq data.

Frontiers in pharmacology·2026

Cancer-associated fibroblasts from cervical cancer modulate protumoral neutrophil functions: evidence from a pilot exploratory study.

Frontiers in immunology·2026

Comparison of feasibility, inter-instrument agreement, and prognostic value of four frailty assessment instruments in geriatric colorectal cancer patients: a 3-year multicenter prospective cohort study.

Frontiers in oncology·2026

Study on the promoting effect of microplastic exposure on prostate cancer migration and invasion based on network toxicology and single-cell sequencing technology.

Frontiers in oncology·2026

Related Experiment Videos

[Estrogen and progesterone receptors in cancer of the breast]

Related Concept Videos

Digital health technology in oncology: results from a survey by the ESMO Young Oncologists Committee and medical student alumni.

Opportunities and challenges in implementing digital patient-centred cancer care in Europe-a qualitative study of several ESMO Designated Centres.

Prognostic impact of pathological complete response and response-adapted outcomes in patients with gastroesophageal adenocarcinoma treated with neoadjuvant or perioperative treatments: a multicentric cohort study.

Gastric cancer hospital-based registry: real-world gastric cancer data from Latin America and Europe.

Clinical decision impact of HER2DX, an algorithm-powered genomic diagnostic in early-stage HER2-positive breast cancer: results from a prospective real-world study.

Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial.

Q fever in Spain: Epidemiology and demographic characteristics of hospitalized patients (2016-2023).

Disease progression in transthyretin cardiac amyloidosis treated with disease-modifying therapies: a multicenter real-world experience.

Allergic bronchopulmonary aspergillosis as a poor prognostic factor in cystic fibrosis patients with atelectasis.

Overview of breast cancer screening in Spain and its impact on mortality: An ecological study examining temporal trends (2000-2023).

One-year outcomes in patients with heart failure and chronic kidney disease: differences according to the type of heart failure and kidney disease stages.

Agent-based simulation and digital twins in heart failure care: Current evidence, validation and implementation barriers.

Exploratory machine-learning analysis of bevacizumab exposure and circulating VEGF dynamics in patients with cancer.

Ulcerative colitis reporting across medications: FAERS analysis and cross-species transcriptomic triangulation.

A novel CAF-related gene signature for prognostic and immunotherapy response prediction in PDAC based on single-cell RNA-seq and bulk RNA-seq data.

Cancer-associated fibroblasts from cervical cancer modulate protumoral neutrophil functions: evidence from a pilot exploratory study.

Comparison of feasibility, inter-instrument agreement, and prognostic value of four frailty assessment instruments in geriatric colorectal cancer patients: a 3-year multicenter prospective cohort study.

Study on the promoting effect of microplastic exposure on prostate cancer migration and invasion based on network toxicology and single-cell sequencing technology.

Related Experiment Videos

[Estrogen and progesterone receptors in cancer of the breast]

Related Concept Videos

Related Articles